Mov Disord Vol 34, Suppl 2 Archives - Page 171 of 217 - MDS Abstracts

2019 International Congress
Spoken Language Profiles in Parkinson’s Disease: A Potential ‘Biomarker’ of Cognitive Change?
A. Roberts (Evanston, IL, USA)
Objective: To Investigate the differences in spoken language profiles of individuals with Parkinson’s disease (PD) compared to healthy controls (HC). Background: In the absence of…
2019 International Congress
Relationship between eye movements during natural reading and basic oculomotor tasks in PD
J. Waldthaler, L. Stock, C. Krüger-Zechlin, L. Timmermann (Marburg, Germany)
Objective: To investigate the relationship of eye movement characteristics during natural, self-paced reading and basic visually-guided saccades (VGS) and antisaccades (AS) tasks in PD. Background:…
2019 International Congress
DNAJC13 in Parkinson’s disease; characterization of the p.N855S knock-in mouse model
J. Follett, J. Fox, E. Gustavsson, M. Farrrer (Vancouver, BC, Canada)
Objective: To study the effects of DNAJC13 p.Asn855Ser mutant gene dysfunction in a physiological context, and to help define molecular mechanisms for disease, using a…
2019 International Congress
Pathological role of GBA2 in GBA1-related disorder
E. Nakanishi, N. Uemura, H. Akiyama, M. Kinoshita, H. Yamakado, S. Takeda, Y. Hirabayashi, R. Takahashi (Kyoto, Japan)
Objective: This study was performed to determine the pathological role of the non-lysosomal β-Glucosidase (GBA2) in the CNS in Gaucher’s disease (GD) and GBA1-related Parkinson's…
2019 International Congress
Hypermethylation of PGC-1α in peripheral blood leukocytes of patients with Parkinson’s disease
X. Yang, SQ. Xu, W. Qian, Q. Xiao (Shanghai, China)
Objective: We aimed to explore the hypothesis that the PGC-1α variants are associated with its promoter methylations level thus affecting the PGC-1α mRNA expression. We…
2019 International Congress
Use of e-PROMs in Parkinson’s disease clinics: A qualitative study of healthcare professionals perceptions
A. Khardali, L. Hughes, E. Lane (Cardiff, United Kingdom)
Objective: To explore the views of PD healthcare professionals on the use of e-PROMs. Background: Assessment of motor AND non-motor symptoms are critical to the…
2019 International Congress
The Nigeria Parkinson Disease Registry
O. Ojo, S. Abubakar, K. Wahab, O. Olugbo, E. Nwazor, O. Oshinaike, A. Bello, U. Williams, O. Ekenze, N. Okubadejo, NPD. Collaborators (Idi-Araba, Nigeria)
Objective: To describe the methodology and preliminary baseline data from the Nigeria Parkinson Disease Registry (NPDR). Background: Disease registries offer an opportunity to expand the…
2019 International Congress
New epidemiological data of Parkinson’s Disease in Ukraine
Y. Trufanov, N. Svyrydova, A. Galusha, V. Svistun, I. Harkava, H. Bondarenko, N. Zhhilova (Kyiv, Ukraine)
Objective: To compare the prevalence of Parkinson’s Disease (PD) in Ukraine in 2010 and 2017; to compare the prevalence of PD in Ukraine with other…
2019 International Congress
Patterns of brain activity linked to Mild Behavioral Impairment in Parkinson’s disease
EJ. Yoon, Z. Ismail, M. Kibreab, T. Hammer, J. Cheetham, I. Kathol, M. Ramezani, S. Lang, J. Sarna, D. Martino, S. Furtado, O. Monchi (Calgary, AB, Canada)
Objective: To evaluate the association between Mild Behavioral Impairment (MBI) and pattern of brain activity during a set-shifting task in Parkinson’s disease (PD). Background: MBI…
2019 International Congress
What can predict short and long-term outcome of bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s disease?
F. Cavallieri, V. Fraix, D. Mulas, F. Bove, M. Tondelli, P. Pélissier, A. Castrioto, S. Meoni, E. Schmitt, E. Chevrier, E. Lhommée, A. Bichon, A. Kistner, C. Ardouin, P. Limousin, S. Chabardès, AL. Benabid, E. Seigneuret, P. Krack, P. Pollak, E. Moro (Grenoble, France)
Objective: To define preoperative predictive factors of short- and long-term motor outcome from a large cohort of consecutive Parkinson’s Disease (PD) patients operated on with…